112197-76-9Relevant articles and documents
2-Methyl-1,3-dioxaazaspirodecanes as Novel Muscarinic Cholinergic Agonists
Saunders, John,Showell, Graham A.,Snow, Roger J,Baker, Raymond,Harley, Elizabeth A.,Freedman, Stephen B.
, p. 486 - 491 (1988)
Many nonquaternary ammonium muscarinic agonists have been developed over the last few years, but most of the existing compounds (e.g., arecoline, RS-86, AF-30) behave as weak partial agonists at cholinergic receptors in tissues of limited receptor reserve
HPK1 ANTAGONISTS AND USES THEREOF
-
Paragraph 0844; 0845, (2021/03/19)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.
